Dear Sinai Residents, Employees, Families, Friends, and Doctors;
I hope this letter finds you Healthy & Safe!
To ensure the safety of our residents and employees we are continuing Covid-19 testing of Residents & Employees weekly due to the high prevalence of Covid in the community. In transparency the facility currently has No residents that have tested positive for Covid-19 and 3 Covid positive residents that were newly admitted to the Covid Recovery unit. There is currently 1 employee that is positive for COVID-19. The facility currently remains in outbreak mode. Unfortunately, we suffered with the total loss of 21 Residents to the Covid-19 virus. We ask that everyone remains vigilant with PPE & mask usage and we continuously encourage safe social distancing.
*** The First COVID-19 VACCINE CLINIC was scheduled Wednesday 12/30/2020. Walgreens was at Sinai Post Acute providing the Pfizer vaccine to all residents and employees that gave consent. There is still an opportunity to request the vaccine for the 1/20/2021 distribution date- please provide consent via the unit manager or nurse before 1/8/2021 if you are interested in the vaccine. The second vaccination dose will be provided on 1/20/2021.
Any family that would like to arrange for a facetime phone call, outdoor visitation, essential caregiver visit, or end of life visit can either contact the social services department or leave a voice mail at 973-483-6800×117. ** Please Note – outdoor visits will be cancelled / rescheduled due to extreme weather conditions such as Rain or Temperatures below 45 degrees**. Please note that the City of Newark is highly discouraging any visits at this time that are not related to end of life.
For all urgent inquiries, please call us 24/7 at 973-483-6800 or email us at email@example.com.
** Please note the Emergency Outbreak Plan is posted to the Sinai Website for review.
Please remember to check our Website for updates that are posted regularly
As always, we thank you for your continued support and pray that everyone stays safe.